The global varicose vein treatment market size is expected to reach USD 2,052.48 million by 2032, according to a new study by Polaris Market Research. The report “Varicose Vein Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Mode (Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation/Stripping); By Products; By End User; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Varicose veins are veins that are unusually enlarged and may protrude close to the skin's surface. Legs are most prone to developing these blue, red, or purple veins, which can occasionally resemble squiggly or rope-like lines. Over 30% of people in Western countries suffer from varicose veins, a prevalent symptom of chronic venous illness. Between the ages of 40 and 80, more than 11 million men and 22 million women in America suffer from chronic venous illness. If neglected, it can lead to several health issues, including leg ulcers and eventually amputations.
The first-ever genetic risk score for predicting the likelihood that patients with varicose veins will need surgery is established in a new international study by Oxford researchers and published on June 2, 2022, in Nature Communications. The study also points the way towards potential new treatments. This represents a rise in research and development activities for treating varicose veins. This can help people with varicose vein problems cure their problems effectively with rising varicose vein treatments in the future.
Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/varicose-vein-treatment-market/request-for-sample
Growing clinics investing in varicose vein treatment are driving the expansion of varicose vein treatment on a global level. Veincentre Clinic was established in Woking, aiming to provide patients with safe, efficient, and less invasive laser therapy to get rid of varicose veins and thread veins. Endovenous laser ablation (Evla) and foam sclerotherapy are two treatments offered in this clinic, where these procedures are regarded as effective varicose vein treatments by the National Institute of Health and Care Excellence. As consumers face rising varicose vein issues due to immobility in the workplace, there is more likely to be a growing demand for varicose vein treatments in the coming years.
Varicose Vein Treatment Market Report Highlights
Polaris Market Research has segmented the varicose vein treatment market report based on treatment mode, products, end user and region:
Varicose Vein Treatment, Treatment Mode Outlook (Revenue - USD Million, 2019 - 2032)
Varicose Vein Treatment, Products Outlook (Revenue - USD Million, 2019 - 2032)
Varicose Vein Treatment, End User Outlook (Revenue - USD Million, 2019 - 2032)
Varicose Vein Treatment, Regional Outlook (Revenue - USD Million, 2019 - 2032)
Report Attributes |
Details |
Market size value in 2024 |
USD 1249.54 million |
Revenue forecast in 2032 |
USD 2,052.48 million |
CAGR |
6.40% from 2023 - 2032 |
Base year |
2023 |
Historical data |
2019 - 2022 |
Forecast period |
2024 - 2032 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2032 |
Segments covered |
By Treatment Mode, By Product, By End User, By Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Customization |
Report customization as per your requirements with respect to countries, region, and segmentation. |
For Specific Research Requirements |